Clinical Trial Update: Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer [Phase 1, Phase 2]

View source ↗

Summary

Open-label Phase 1/2 trial update evaluating INX-315 in patients with advanced cancers, including breast and ovarian cancer, with recruitment ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Ovarian Cancer

Drugs mentioned

• INX-315

Snippet

Sponsor: Incyclix Bio | Conditions: Breast Cancer, Breast Cancer Metastatic | Phase 1, Phase 2 | Status: RECRUITING